Missouri Trust & Investment Company’s Amgen AMGN Stock Holding History

Missouri Trust & Investment Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-285	Closed	-$100K	–	158
2026 Q1	$100K	Buy	285 +4	+1%	+$1.43K	0.03%	177
2025 Q4	$92K	Hold	281	–	–	0.03%	176
2025 Q3	$79.3K	Hold	281	–	–	0.02%	182
2025 Q2	$78.5K	Sell	281 -26	-8%	-$7.37K	0.03%	177
2025 Q1	$95.6K	Buy	307 +43	+16%	+$12.7K	0.03%	160
2024 Q4	$68.8K	Buy	264 +27	+11%	+$8.01K	0.02%	188
2024 Q3	$76.4K	Hold	237	–	–	0.03%	181
2024 Q2	$74.1K	Hold	237	–	–	0.03%	170
2024 Q1	$67.4K	Hold	237	–	–	0.03%	184
2023 Q4	$68.3K	Buy	237 +12	+5%	+$3.27K	0.03%	176
2023 Q3	$60.5K	Hold	225	–	–	0.03%	171
2023 Q2	$50K	Hold	225	–	–	0.03%	190
2023 Q1	$54.4K	Hold	225	–	–	0.04%	158
2022 Q4	$59K	Hold	225	–	–	0.04%	163
2022 Q3	$51K	Hold	225	–	–	0.03%	170
2022 Q2	$55K	Hold	225	–	–	0.04%	168
2022 Q1	$54K	Sell	225 -10	-4%	-$2.3K	0.03%	180
2021 Q4	$53K	Buy	+235	New	+$49.6K	0.03%	187

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Missouri Trust & Investment Company's AMGN Position: Q2 2026 in Review

Missouri Trust & Investment Company sold out of Amgen (AMGN) in Q2 2026, closing a stake of 285 shares — an estimated $100K sold.

Missouri Trust & Investment Company first reported a position in AMGN in Q4 2021 and held it in 18 quarters. The position peaked at $100K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Missouri Trust & Investment Company reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Missouri Trust & Investment Company sold 285 Amgen shares in Q2 2026, an estimated $100K.
Missouri Trust & Investment Company first reported a position in Amgen in Q4 2021 and held it in 18 quarters.
Missouri Trust & Investment Company's Amgen position peaked at $100K in Q1 2026.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.